Skip to main content
. 2024 May 21;24:263. doi: 10.1186/s12872-024-03929-5

Table 3.

Patients’ characteristics and MACE among the three groups according to CHA2DS2-VASc-HSF score

Variables Low score group
(29 patients)
Intermediate score group
(83 patients)
High score group
(88 patients)
p-value
Age (years) 51.93 ± 11.28 54.10 ± 8.91 58.76 ± 10.14 0.003
Congestive Heart Failure 0 5 (6.0) 19 (21.6) 0.001
Hypertension 11 (37.9) 44 (53.0) 63 (71.6) 0.002
Age ≥ 75 years 0 0 7 (8.0) 0.01
DM 6 (20.7) 29 (34.9) 62 (70.5) < 0.001
Prior stroke or TIA 0 1 (1.2) 4 (4.5) 0.24
Vascular disease 0 23 (27.7) 57 (64.8) < 0.001
Age (65–74 years) 4 (13.8) 13 (15.7) 25 (28.4) 0.07
Male sex 10 (34.5) 60 (72.3) 75 (85.2) < 0.001
Hyperlipidemia 4 (13.8) 56 (67.5) 87 (98.9) < 0.001
Smoking 6 (20.7) 43 (51.8) 68 (77.3) < 0.001
Family history of CAD 1 (3.4) 22 (26.5) 31 (35.2) 0.004
Syntax score 4.48 ± 6.57 12.71 ± 9.11 24.60 ± 11.80 < 0.001
MACE 0 3 (3.6) 13 (14.8) 0.006
Death 0 0 1 (1.1) 0.528
Nonfatal MI 0 1 (1.2) 6 (6.8) 0.074
Nonfatal stroke 0 1 (1.2) 4 (4.5) 0.243
Hospitalization for UA 0 1 (1.2) 2 (2.3) 0.655

Data are expressed in the form of mean ± SD or frequency (%).

CAD: coronary artery disease; DM: diabetes mellitus; MACE: major adverse cardiovascular events; MI: myocardial infarction; TIA: transient ischemic attack; UA: unstable angina.